On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Vironova AB's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.7M · 2 projects
- Horizon 2020€0 · 1 project
Projects
3 EU-funded projects, newest first. Vironova AB led 2 of them as coordinator. Each links to the official record.
- MAD-CoV 2Partner
Modern approaches for developing antivirals against SARS-CoV 2
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
- FLUCURECoordinator
Development of novel antiviral drugs against Influenza
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€1.2Mtheir share - FLUDRUGSTRATEGYCoordinator
Combating influenza using a novel drug strategy
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
€447ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universitaetsklinikum FreiburgGermany · 2 shared projects
- Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en PatientenzorgNetherlands · 2 shared projects
- Beactica Therapeutics ABSweden · 2 shared projects
- Institute of Organic Chemistry With Centre of Phytochemistry - Bulgarian Academy of SciencesBulgaria · 2 shared projects
- Stichting VuNetherlands · 1 shared project
- Medizinische Universitaet WienAustria · 1 shared project
- Fundacio Institut de Bioenginyeria de CatalunyaSpain · 1 shared project
- Universita Degli Studi di SienaItaly · 1 shared project
- Institut Fuer Molekulare Biotechnologie GmbHAustria · 1 shared project
- Justus-Liebig-Universitaet GiessenGermany · 1 shared project
- Vilniaus UniversitetasLithuania · 1 shared project
- Inserm Transfert SAFrance · 1 shared project
- Statens Veterinaermedicinska AnstaltSweden · 1 shared project
- Stemcell Technologies UK LtdUnited Kingdom · 1 shared project
- Pike Pharma GmbHSwitzerland · 1 shared project
- Pharmacelsus GmbHGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- antivirals
- coronaviruses
- drug discovery
- ebola
- influenza
- pandemics
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗